July 28, 2026 · Form 4 insider transaction
Sollie-Zetlmayer Hege Elisabeth bought 1,738 shares of PTC Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
This option was granted on July 28, 2026 and vests over six equal monthly installments, commencing on August 2, 2026.